GL1X · GenesisL1 explorer

MolNFT v1 · #77573 · protein

Plant steroid receptor BRI1 ectodomain in complex with brassinolide

3RJ0 · Protein brassinosteroid insensitive 1: “Plant steroid receptor BRI1 ectodomain in complex with brassinolide”. X-ray diffraction, 4 ligands (BLD, NAG, BMA), 3 pockets (best druggability 0.58). MolNFT v1 #77573 on GenesisL1: 3D…

PDB
3RJ0
Type
protein
Length
741 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein brassinosteroid insensitive 1
EC
2.7.10.1, 2.7.11.1
UniProt
O22476
Ligands
BLD, NAG, BMA, MAN
Pockets
3 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 18% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein brassinosteroid insensitive 1 (EC 2.7.10.1, 2.7.11.1)protein74118% helix, 24% strandO22476

Ligands and binding sites

  • BLD · Brassinolide · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 9 copies · chains A
  • BMA · beta-D-mannopyranose · sugar · 3 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11980.580.7922BLD
21140.480.8023empty
3630.380.7917empty

Modifications

Observed in the structure: 8 disulfide, 6 glycan (disulfide, N-glycosylation).

Compared structures

  • 3RJ0 · Plant steroid receptor BRI1 ectodomain in complex with brassinolide · the same entry in another collection · chain A against A, TM-score 1.00
  • O22476 · AlphaFold monomer V2.0 prediction for protein brassinosteroid insensitive 1 (O22476) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.